Myosin Inhibitors for the Treatment of Obstructive Hypertrophic Cardiomyopathy: A Canadian Perspective on a First-in-Class Therapy
Can J Physiol Pharmacol. 2025 Nov 12. doi: 10.1139/cjpp-2025-0124. Online ahead of print. ABSTRACT Hypertrophic cardiomyopathy (HCM) is a relatively common heritable cardiac condition (~1 …